48-Hour Policy Issuance Eliminates Traditional Bottleneck for Clinical Trials

SPG Canada- Cansure: The Clinical Trials Insurance Partner Built for Canadian Brokers

March 26, 2026

Canada Is at the Centre of the Global Clinical Trials Boom

The federal government has committed over $103 million to 36 domestic trial projects since 2022, including $43.1 million invested in August 2024 for 14 new trials addressing cancer, sepsis, stroke, and antimicrobial resistance. These investments are part of a broader $2.2 billion Biomanufacturing and Life Sciences Strategy — Canada’s largest-ever commitment to life sciences infrastructure.

The global backdrop amplifies that opportunity further. The clinical trials market reached $84.5 billion in 2024 and is on track to reach $158 billion by 2033 — a sustained 7.5% annual growth rate. North America holds over 50% of global trial activity, meaning the volume of potential clients — sponsors, CROs, and academic research institutions — is growing year over year for Canadian brokers.

The challenge has never been demand. It has been speed — and the insurance process has historically been the single biggest drag on it.

The Speed Problem: When Insurance Becomes the Bottleneck

Research Ethics Boards (REBs) across Canada require proof of insurance coverage before approving any trial — making it a hard regulatory gate, not a formality. When that gate is slow, everything stops.

Approximately 80% of trials already face recruitment delays, and an insurance bottleneck compounds that pressure directly. Patient recruitment alone accounts for roughly 40% of total trial costs — an estimated $1.89 billion annually in North America. Every day a Research Ethics Board waits on insurance confirmation is a day of budget burn with no clinical progress to show for it.

For brokers, that bottleneck is a business opportunity. SPG Canada-Cansure has built a placement process that lets brokers deliver a fast, professional answer to clients at the exact moment they need it most — turning a pain point that has stalled deals for years into a competitive advantage.

Health Canada Regulatory Deadline: April 1, 2026- Act Now

NEW REGULATORY REQUIREMENT: Health Canada is implementing updated Good Clinical Practice standards — ICH E6(R3) — effective April 1, 2026. This aligns Canada with international best practices and raises the compliance bar on documentation, site oversight, and insurance requirements for all trial sponsors.

This is the most significant update to clinical trial oversight standards in decades, and it raises the compliance bar meaningfully across three areas:

• Documentation: ICH E6(R3) requires more rigorous audit trails and data integrity standards across all trial phases.
• Site Oversight: Sponsors must demonstrate enhanced oversight of investigative sites, including risk-based monitoring frameworks that require documented insurance structures.
• Insurance Requirements: Sponsors must have a properly structured insurance partner in place. Informal or undocumented coverage arrangements will no longer satisfy REB and regulatory review.

Sponsors who do not have a properly structured insurance partner in place before April 1 will feel the impact immediately — delayed REB approvals, stalled site activations, and potential compliance findings. Brokers who already have a clinical trials capacity partner in place will be the first call sponsors make as that deadline approaches.

The regulatory momentum in Canada is real, the government investment is real, and the demand from sponsors and CROs for brokers who understand this space is accelerating.

“ We’ve eliminated the traditional proposal form and replaced a process that used to take weeks with a 48-hour turnaround — because when every day of delay matters, speed isn’t a differentiator. It’s a requirement.”
— Ashley Scandlan, AVP Professional Services

SPG Canada- Cansure’s clinical trials insurance covers all trial phases (Phase I–IV) across 115+ countries, with flexible policy terms available up to 10 years. Brokers who bring a submission today get a quote within 48 hours.

Ready to Place a Clinical Trials Risk?
Brokers with clinical trials clients can submit directly at:
Email: underwriting@spgcanada.ca
Quotes returned within 48 hours
No proposal forms. No back-and-forth.